Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMA and renal endothelial dysfunction
NL-OMON20074Not yet recruiting
- Sponsor
- Dr. A.A. Kroon P. Debyelaan 25, P.O. Box 5800 6202 AZ Maastricht Phone: +31 43 387 7005 (secretary
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of resomelagon, ulinastatin and NG-monomethyl-L-arginine in hypertension (HTN) and Renal Insufficiency (RI), sponsored by Dr. A.A. Kroon P. Debyelaan 25, P.O. Box 5800 6202 AZ Maastricht Phone: +31 43 387 7005 (secretary. Primary endpoints: Basal renal perfusion, Fractional change in renal perfusion after intrarenal L-NMMA infusion and 2 more. Planned start Nov 2008; status: not yet recruiting.
02
Drugs
resomelagonulinastatinNG-monomethyl-L-arginine
03
Conditions
hypertension (HTN)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NL-OMON20074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20074.